FLUOCYNE 10% clinical trials

Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis (JAKUVEITE)

This study is looking at a new tablet treatment called baricitinib (Olumiant) for a type of eye inflammation called uveitis. Researchers want to see if it can help improve symptoms and reduce the need for other medications over six months.